abstract |
The present invention relates to a pharmaceutical composition for the prevention or treatment of non-alcoholic fatty liver disease or dyslipidemia comprising an aminoalkylbenzothiazepine derivative or a pharmaceutically acceptable salt thereof as an active ingredient. |